Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Octreoscan radioreceptor imaging.

Aart J van der Lely1, Wouter W de Herder, Eric P Krenning

  • 1Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands. vanderlely@inw3.azr.nl

Endocrine
|May 2, 2003
PubMed
Summary

Peptide receptor scintigraphy, using Octreoscan, effectively visualizes somatostatin-receptor-positive tumors. This imaging technique is valuable for staging neuroendocrine tumors and Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Multicenter Phase II Randomized Controlled Trial Comparing 177Lu-Dotatate/Capecitabine Combination Treatment with 177Lu-Dotatate Monotherapy in Patients with Neuroendocrine Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Relationship Between Best Tumor Shrinkage and Progression-Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [<sup>177</sup>Lu]Lu-DOTA-TATE: Ad Hoc Analysis of the Phase III NETTER-1 Trial.

Cancer medicine·2025
Same author

Reshaping [<sup>99m</sup>Tc]Tc-DT11 to DT14D Tagged with Trivalent Radiometals for NTS<sub>1</sub>R-Positive Cancer Theranostics.

Pharmaceutics·2025
Same author

Diagnosis of Prostate Cancer with a Neurotensin-Bombesin Radioligand Combination-First Preclinical Results.

Pharmaceutics·2024
Same author

Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.

Frontiers in endocrinology·2024
Same author

Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [<sup>111</sup>In]In-Radioligands: Synthesis and Preclinical Profile.

International journal of molecular sciences·2024

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiopharmacology

Background:

  • Peptide receptor scintigraphy emerged 15 years ago for in vivo tumor visualization.
  • Octreoscan is a key radiopharmaceutical for imaging somatostatin-receptor-positive tumors.
  • Somatostatin receptor imaging demonstrates high overall sensitivity.

Purpose of the Study:

  • To evaluate the clinical utility of somatostatin receptor imaging.
  • To highlight the role of Octreoscan in tumor localization and staging.

Main Methods:

  • In vivo demonstration of somatostatin-receptor-positive tumors.
  • Utilizing radiolabeled somatostatin analogs.
  • Application of peptide receptor scintigraphy.

Main Results:

  • Octreoscan is clinically important for visualizing somatostatin-receptor-positive tumors.
  • Somatostatin receptor imaging is highly sensitive.
  • Imaging is beneficial for staging neuroendocrine tumors and Hodgkin's disease.

Conclusions:

  • Somatostatin receptor imaging, particularly with Octreoscan, is a valuable tool for specific tumor types.
  • Further studies are needed to establish its role in breast cancer and granulomatous diseases.

Related Experiment Videos